Akribion Therapeutics is a series c plus startup based in Germany. 1 investor tracked. Status: dead.
Akribion Therapeutics is a company headquartered in Germany. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Akribion Therapeutics is a biotechnology company focused on developing new therapies for cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.